![Paula O’Connor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paula O’Connor
Directeur Technique/Scientifique/R&D chez
NURIX THERAPEUTICS, INC.
Profil
Paula G.
O’Connor is Chief Medical Officer at Nurix Therapeutics, Inc. since 2024.
Formerly, Dr. O’Connor was Senior Vice President-Clinical Development at Protagonist Therapeutics, Inc. Education includes a doctorate from Stanford University School of Medicine and an undergraduate degree from Yale University.
Postes actifs de Paula O’Connor
| Sociétés | Poste | Début |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2022 |
Anciens postes connus de Paula O’Connor
| Sociétés | Poste | Fin |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2022 |
Formation de Paula O’Connor
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
